Observational studyInternal medicine (Tokyo, Japan)2024

Daily Glucose Profiles after Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes Mellitus.

Mitsuyoshi Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.